Advertisement

Topics

BRIEF-Abbvie presents data on eight-week treatment of VIEKIRAX

00:07 EDT 23 Sep 2016 | Reuters

* Two patients experienced post-treatment relapse and one subject discontinued due to noncompliance

Original Article: BRIEF-Abbvie presents data on eight-week treatment of VIEKIRAX

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Abbvie presents data on eight-week treatment of VIEKIRAX"

Quick Search
Advertisement